| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042886577 |
| P356 | DOI | 10.1023/B:THRO.0000036023.14285.C5 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1023/b:thro.0000036023.14285.c5 |
| P698 | PubMed publication ID | 15277782 |
| P2093 | author name string | Robert A Harrington | |
| William C Dixon | |||
| P2860 | cites work | Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 |
| Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) | Q28282299 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| Tissue plasminogen activator for acute ischemic stroke | Q29619377 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 | ||
| The role of inflammation in vascular diseases. | Q30305653 | ||
| Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset | Q30436402 | ||
| Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data | Q30671597 | ||
| Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. | Q31873739 | ||
| A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. | Q33504515 | ||
| Assessing the role of gene therapy in the treatment of vascular disease. | Q33878470 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease | Q34687253 | ||
| Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review | Q38554587 | ||
| Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention | Q40689430 | ||
| Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial | Q42050512 | ||
| Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions | Q43472007 | ||
| Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease | Q43614603 | ||
| Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | Q45208371 | ||
| A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group | Q47303123 | ||
| Selective Clot Lysis with Low-Dose Streptokinase | Q47886263 | ||
| Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes | Q48481153 | ||
| Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials | Q56944618 | ||
| The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators | Q68200357 | ||
| RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 | Q69755626 | ||
| Clopidogrel versus ticlopidine after intracoronary stent placement | Q73250221 | ||
| AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association | Q73318145 | ||
| The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group | Q73396117 | ||
| CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group | Q73422585 | ||
| Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study | Q73505522 | ||
| Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S) | Q74190871 | ||
| Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial | Q74652075 | ||
| New antithrombotic agents | Q77579087 | ||
| Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease | Q77710135 | ||
| Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia | Q78019724 | ||
| P433 | issue | 1 | |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 5-9 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Thrombosis and Thrombolysis | Q15766541 |
| P1476 | title | Multi-bed vascular disease: past, present, and future | |
| P478 | volume | 17 |
Search more.